Generic drugs the pay-for-delay problem /
Guardat en:
| Autor corporatiu: | |
|---|---|
| Altres autors: | |
| Format: | Electrònic eBook |
| Idioma: | anglès |
| Publicat: |
New York :
Nova Biomedical/Nova Science Publishers,
c2011.
|
| Col·lecció: | Public health in the 21st century series.
|
| Matèries: | |
| Accés en línia: | An electronic book accessible through the World Wide Web; click to view |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Ítems similars
Generic drugs the pay-for-delay problem /
Publicat: (2011)
Publicat: (2011)
Pharmaceutical pricing policies in a global market
Publicat: (2008)
Publicat: (2008)
Pharmaceutical pricing policies in a global market
Publicat: (2008)
Publicat: (2008)
Les prix des medicaments sur un marche global politiques et enjeux.
Publicat: (2008)
Publicat: (2008)
Les prix des medicaments sur un marche global politiques et enjeux.
Publicat: (2008)
Publicat: (2008)
Generic drugs needs and issues /
Publicat: (2009)
Publicat: (2009)
Generic drugs needs and issues /
Publicat: (2009)
Publicat: (2009)
The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
Publicat: (1983)
Publicat: (1983)
The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
Publicat: (1983)
Publicat: (1983)
The $800 million pill the truth behind the cost of new drugs /
per: Goozner, Merrill, 1950-
Publicat: (2004)
per: Goozner, Merrill, 1950-
Publicat: (2004)
The $800 million pill the truth behind the cost of new drugs /
per: Goozner, Merrill, 1950-
Publicat: (2004)
per: Goozner, Merrill, 1950-
Publicat: (2004)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
per: Osmane, Malik
Publicat: (2014)
per: Osmane, Malik
Publicat: (2014)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
per: Osmane, Malik
Publicat: (2014)
per: Osmane, Malik
Publicat: (2014)
Driving down the cost of drugs : battling big pharma in the statehouse /
per: Castellblanch, Ram�on, 1948-
Publicat: (2012)
per: Castellblanch, Ram�on, 1948-
Publicat: (2012)
Driving down the cost of drugs : battling big pharma in the statehouse /
per: Castellblanch, Ram�on, 1948-
Publicat: (2012)
per: Castellblanch, Ram�on, 1948-
Publicat: (2012)
Pharmaceutical economics and policy
per: Schweitzer, Stuart O.
Publicat: (2007)
per: Schweitzer, Stuart O.
Publicat: (2007)
Pharmaceutical economics and policy
per: Schweitzer, Stuart O.
Publicat: (2007)
per: Schweitzer, Stuart O.
Publicat: (2007)
The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
Publicat: (2003)
Publicat: (2003)
The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
Publicat: (2003)
Publicat: (2003)
Profits before people? ethical standards and the marketing of prescription drugs /
per: Weber, Leonard J., 1942-
Publicat: (2006)
per: Weber, Leonard J., 1942-
Publicat: (2006)
Profits before people? ethical standards and the marketing of prescription drugs /
per: Weber, Leonard J., 1942-
Publicat: (2006)
per: Weber, Leonard J., 1942-
Publicat: (2006)
Marketing strategies adopted by generic and original drugs companies in an effort to attain strategic competitiveness: a study of Mombasa /
per: Matingi, Ireen Mueni
Publicat: (2013)
per: Matingi, Ireen Mueni
Publicat: (2013)
CAPA for the FDA-regulated industry /
per: Rodríguez Pérez, José, 1961-
Publicat: (2010)
per: Rodríguez Pérez, José, 1961-
Publicat: (2010)
CAPA for the FDA-regulated industry /
per: Rodríguez Pérez, José, 1961-
Publicat: (2010)
per: Rodríguez Pérez, José, 1961-
Publicat: (2010)
The risks of prescription drugs
Publicat: (2010)
Publicat: (2010)
The risks of prescription drugs
Publicat: (2010)
Publicat: (2010)
ADME-enabling technologies for drug design and development
Publicat: (2012)
Publicat: (2012)
ADME-enabling technologies for drug design and development
Publicat: (2012)
Publicat: (2012)
Drug discovery and design medical aspects /
Publicat: (2002)
Publicat: (2002)
Drug discovery and design medical aspects /
Publicat: (2002)
Publicat: (2002)
Drugs : from discovery to approval /
per: Ng, Rick
Publicat: (2015)
per: Ng, Rick
Publicat: (2015)
Drugs : from discovery to approval /
per: Ng, Rick
Publicat: (2015)
per: Ng, Rick
Publicat: (2015)